IGFBP6 Human

IGFBP-6 Human Recombinant

IGFBP6 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing amino acids 148-240 and having a molecular mass of 20 kDa including 4kDa His tag.
IGFBP6 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT16971
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.

IGFBP6 Mouse

Insulin Like Growth Factor Binding Protein-6 Mouse Recombinant

IGFBP6 Mouse Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 221 amino acids (26-238 a.a.) and having a molecular mass of 23.7kDa (Migrates at 28-40kDa on SDS-PAGE under reducing conditions).
IGFBP6 is expressed with a 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17059
Source
Sf9, Baculovirus cells.
Appearance
Sterile Filtered colorless solution.

IGFBP7 Human

Insulin-Like Growth Factor Binding Protein-7 Human Recombinant

Recombinant Human IGFBP7 produced in E.coli cells is a non-glycosylated, homodimeric protein containing 2x256 amino acid chains and having a molecular mass of 26.4kDa.
The IGFBP-7 is purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT17129
Source
Escherichia Coli.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Definition and Classification

Insulin-like growth factor binding proteins (IGFBPs) are a family of proteins that bind to insulin-like growth factors (IGFs) with high affinity. There are six distinct types of IGFBPs in vertebrates: IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-5, and IGFBP-6 . These proteins play a crucial role in regulating the availability and activity of IGFs by extending their half-life and modulating their interaction with IGF receptors .

Biological Properties

Key Biological Properties: IGFBPs are present in all biological fluids and have a molecular weight ranging from 24 to 45 kDa . They share significant sequence homology and have binding affinities for IGF-I and IGF-II .

Expression Patterns: The expression of IGFBPs varies across different tissues and developmental stages. For example, IGFBP-3 is the most abundant and accounts for 80% of all IGF binding .

Tissue Distribution: IGFBPs are widely distributed in various tissues, including the liver, prostate, and other organs . Their expression can be influenced by physiological conditions and disease states .

Biological Functions

Primary Biological Functions: IGFBPs regulate the bioavailability of IGFs, thereby influencing cell growth, proliferation, differentiation, and survival . They can either enhance or inhibit IGF signaling depending on the context .

Role in Immune Responses and Pathogen Recognition: IGFBPs have been shown to modulate immune responses and may play a role in pathogen recognition . They can influence the activity of immune cells and the production of cytokines .

Modes of Action

Mechanisms with Other Molecules and Cells: IGFBPs interact with IGFs to regulate their access to IGF receptors . They can also bind to other cell surface receptors, such as integrins and transforming growth factor β (TGF-β) family receptors .

Binding Partners and Downstream Signaling Cascades: IGFBPs can modulate signaling cascades by interacting with various binding partners, including intracellular ligands and nuclear hormone receptors . These interactions can influence gene transcription and cellular functions .

Regulatory Mechanisms

Regulatory Mechanisms: The expression and activity of IGFBPs are controlled by various regulatory mechanisms, including transcriptional regulation and post-translational modifications . Phosphorylation, glycosylation, and proteolysis are some of the post-translational modifications that can affect IGFBP function .

Applications

Biomedical Research: IGFBPs are used as biomarkers in cancer research and other diseases . They can provide insights into disease progression and prognosis .

Diagnostic Tools: IGFBPs are being explored as diagnostic tools for various conditions, including cancer and metabolic disorders .

Therapeutic Strategies: IGFBPs have potential therapeutic applications, such as targeting IGFBP-3 for cancer treatment . Their ability to modulate IGF signaling makes them attractive candidates for drug development .

Role in the Life Cycle

Role Throughout the Life Cycle: IGFBPs play a critical role throughout the life cycle, from development to aging . They are involved in various physiological processes, including growth, metabolism, and tissue repair . Dysregulation of IGFBP expression and function can contribute to aging and age-related diseases .

© Copyright 2024 Thebiotek. All Rights Reserved.